Sven ARNOUTS

Business Development Manager

Ghent University - provaxs

Merelbeke, Belgium

32 profile visitsSpeaker

Passionate about innovations in animal health and translational medicine

My organisation

Merelbeke, Belgium

Your preferred academic partner We can become your preferred academic partner and support your innovation-projects in animal health. We combine scientific expertise, knowledge and know-how on animal health with an entrepreneurial organisation of scientists and experienced tech-transfer professionals. Not only that, but thanks to the Industrial Research Fund of Ghent University we have access to proof-of-concept funding, open for collaboration with industry. Flexibility and tailor-made partnerships We are receptive to all types of collaborations and partnerships: out-licensing and development of our UGent-technologies towards the final product research collaboration on a single project, either bilateral or in a research consortium strategic partnerships with a specific focus/topic. All our collaborations and partnerships are supported by a professional business development/tech-transfer team and are based on solid tailor-made agreements on confidentiality, ownership, and exploitation of results.

About me

As Business Developer Dr. Sven Arnouts coordinates technology transfer for PROVAXS at Ghent University in Belgium.

He facilitates interaction and collaboration between industry and Ghent University's experts in infectious diseases and immunity in animal health. In 2019 he started the One Health Platform at Ghent University.

Dr. Arnouts graduated in 1990 as Bio-engineer in animal breeding and cell and gene technology. In 1994 he obtained his PhD in avian growth physiology and immunology at the University of Leuven on an industrial project in collaboration with Solvay-Duphar. From 1994 to 2006 he was global R&D Manager Agriculture at INVE where he was responsible for research activities in animal nutrition for pigs, poultry and ruminants with a special focus on the relation between nutrition and health.

Dr. Arnouts

is Chairman of the Board of Directors of Immunity for Health since January 2016
represents Belgium in the Executive Committee of the International Research Consortium STAR-IDAZ IRC

Social media

Skills

Technology transfer
Business Development
animal health and welfare

Interests

R&D collaboration
licensing
valorisation
one health collaborations

Additional questions

Interests

VaccinesOther biologicalsLivestockFinancing / Investment / FundingEnabling technology (assay, delivery, formulation, manufacturing, ...)DiagnosticsData / AI / RoboticsCompanion animals

What is your primary goal for attending this event?

Networking with industry professionalsExploring potential collaborationsLearning about the latest trends in healthtechShowcasing products or solutionsUnderstanding regulatory and policy developments

Speaker sessions (3)

Tuesday, 19 May 2026

09:15 - 09:30

Welcome & Introduction

BMCC - 1st Floor - Auditorium

09:30 - 11:00

Workshop: Research with impact - Discoveries Leading to Products

BMCC - 1st Floor - AuditoriumWorkshop

This session explores how academic discoveries can effectively translate into practical animal health solutions

Thursday, 21 May 2026

11:00 - 12:00

Keynote: Trends and technologies transfer across species

BMCC - 1st Floor - AuditoriumKeynote

This keynote delves into the translation of innovations from the human health (HH) sector into the animal health (AH) domain—whether through the adaptation of mature technologies or through concurrent development strategies.

Marketplace (3)

Product
A biological to treat pyoderma
A novel lysin to treat pyoderma caused by Staphylococcus pseudintermedius (SP)
Investor
Industry Partner
Strategic Partner
Licensing Partner
Technology Partner
Manufacturing Partner
Veterinary Therapeutics
Animal Health Biotechnology
Antimicrobial Resistance Solutions
Author
Sven ARNOUTS
Business Development Manager at Ghent University - provaxs
Merelbeke, Belgium
Product
A probiotic to improve udder health
A live probiotic for intrammary improvement of udder health
Industry Partner
Strategic Partner
Licensing Partner
Livestock Farming
Commercial Partner
Technology Partner
Veterinary Therapeutics
Animal Health Biotechnology
Sustainable Livestock Health
Antimicrobial Resistance Solutions
Author
Sven ARNOUTS
Business Development Manager at Ghent University - provaxs
Merelbeke, Belgium
Product
Entry portal through the intestinal barrier
Antibody-based targeting to APN for controlled transfer of biologicals through the intestinal (mucosal) barrier.
Investor
Industry Partner
Strategic Partner
Licensing Partner
Livestock Farming
Commercial Partner
Technology Partner
Veterinary Vaccines
Manufacturing Partner
Animal Health Biotechnology
Antimicrobial Resistance Solutions
Author
Sven ARNOUTS
Business Development Manager at Ghent University - provaxs
Merelbeke, Belgium